PATENT CLAIM ANALYSIS

Application Number: 15874694
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "198000"]

Abstract:
A method for increasing the number of CD4+ T-lymphocytes in the serum of a subject in need of such treatment comprising administering to the subject a pharmaceutical composition comprising an amount of an L-isomer of β-lactam effective to increase the number of CD4+ T-lymphocytes in said patient's serum.

Claim (Index 8):
The method of  claim 1  wherein said subject is a patient exposed to environmental toxins or undergoing cancer therapy.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 86.0
- Lexical Diversity: 1.6129
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13302821', '15478028', '15262618', '11791327', '12139053']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7478303881116269
- 35 USC 102 Novelty (BERT): 0.5160113806770948
- Combined Prediction Score: 0.7246484873681738
- Mean Citation Score: 205.960014
- Max Citation Score: 244.18988
- Similarity Product: 140.58674727190257

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test